Credit Agricole’s Bristol-Myers Squibb BMY Stock Holding History

Credit Agricole’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13M	Buy	225,000 +50,000	+29%	+$2.87M	0.03%	442
2026 Q1	$10.6M	Buy	175,000 +50,000	+40%	+$2.91M	0.03%	384
2025 Q4	$6.74M	Buy	+125,000	New	+$6.01M	0.02%	517
2025 Q1	$6.1M	Sell	100,000 -50,000	-33%	-$2.91M	0.02%	499
2024 Q4	$8.48M	Hold	150,000	–	–	0.02%	433
2024 Q3	$7.76M	Hold	150,000	–	–	0.03%	339
2024 Q2	$6.23M	Buy	150,000 +50,000	+50%	+$2.24M	0.03%	323
2024 Q1	$4.83M	Hold	100,000	–	–	0.05%	260
2023 Q4	$5.13M	Buy	+100,000	New	+$5.25M	0.06%	209

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Credit Agricole's BMY Position: Q2 2026 in Review

Credit Agricole increased its Bristol-Myers Squibb (BMY) stake by 57% in Q2 2026, buying an estimated $25.7M and bringing the position to 1,232,853 shares worth $71M. The position accounts for 0.14% of the portfolio, ranked #121.

Credit Agricole first reported a position in BMY in Q3 2013 and has held it in 51 quarters since. The position peaked at $145M in Q1 2016. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Credit Agricole held 1,232,853 shares of Bristol-Myers Squibb worth $71M as of Q2 2026.
Credit Agricole bought 447,754 Bristol-Myers Squibb shares in Q2 2026, an estimated $25.7M.
Bristol-Myers Squibb made up 0.14% of Credit Agricole's portfolio in Q2 2026, its #121 holding.
Credit Agricole first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 51 quarters since.
Credit Agricole's Bristol-Myers Squibb position peaked at $145M in Q1 2016.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.